eVTOL stocks broke lower together on June 6, but the market was not punishing the same weakness in every name. Joby Aviation closed at $9.55 on 38,269,412 shares, Archer Aviation closed at $5.54 on 52,182,233 shares, and EHang closed at $7.90 on 3,143,312 shares, which set up a session defined by supply pressure, proof gaps, and commercialization friction rather than a single sector-wide verdict.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is Joby’s selloff really about dilution and supply, not a new collapse in fundamentals?
The evidence in today’s source set points much more toward supply overhang than a fresh breakdown in Joby’s long-term industrial story. Quiver Quantitative reported that insiders logged 89 JOBY transactions over the last six months, with only two purchases against 87 sales, and that CFO Rodrigo Brumana was named in the latest insider-sale coverage. On its own, that already hurts confidence because investors tend to read repeated insider selling as a signal that near-term upside may be capped. But the larger issue is mechanical share supply. Quiver also cited Joby’s completed 52,863,437-share equity offering at $11.35, which brought in about $576.3 million of net proceeds, plus a separate 5,286,343-share delta offering tied to the company’s 2032 convertible notes. Added together, that is 58,149,780 shares of fresh or effectively tradeable supply that the market has had to absorb in a short period.
That supply context fits the tape far better than a simple “fundamentals broke” explanation. Joby closed at $9.55, down 14.27%, on 38.3 million shares of volume after the market digested both dilution-linked headlines and insider-sale optics. At the same time, the institutional data was not consistent with broad abandonment. The daily file shows 315 institutions increased positions in the most recent quarter versus 219 that reduced them. D.E. Shaw added 8,557,106 shares, BlackRock added 6,809,994 shares, Citigroup added 3,724,233 shares, and Delta Air Lines added 3,546,481 shares. My read: if large holders were stepping in while the stock still fell this hard, the market was likely struggling with incremental supply more than it was repricing Joby to zero confidence.
The counterargument is that fundamentals are not exactly clean. StocksToTrade said Morgan Stanley cut its target from $15 to $13, and the same source described Joby as a pre-profit company generating about $24.25 million of quarterly revenue while still posting roughly a $110 million net loss. Those numbers matter because they remind investors that even a well-funded eVTOL name is still selling a future operating model, not a mature earnings base. I think that makes the supply shock more dangerous, not less. When a company is pre-profit, extra share issuance and insider selling are judged against a valuation that already depends on patience.
The institutional comparison still matters most. Even the two biggest adds in the source set, D.E. Shaw and BlackRock, total 15,367,100 shares, which is substantial but still far below the 58.1 million-share burden created by the equity raise and delta structure. The way I see it, the market is distinguishing between balance-sheet improvement and float pressure. New capital helps Joby survive and execute. It does not stop the stock from trading poorly while new supply clears.
My directional lean here is cautious to constructive on the business but bearish on the near-term stock path. I do not see today’s data as proof that investors have rejected Joby’s certification or commercialization case outright. I do see a market that is forcing the stock to earn back trust after a large financing event, insider-sale headlines, and a lower sell-side target landed at once. Quiver Quantitative and StocksToTrade both support that reading, while the ARKX snapshot from StockAnalysis shows there is still institutional appetite for the category.
Is Archer getting too much credit for cash while investors wait for public flight-test proof?
I think the market is still giving Archer a generous benefit of the doubt because the cash balance is easy to underwrite while the proof gap is harder to price. The positive case is straightforward. Archer’s average analyst target in the source set is $10.61, well above the $5.54 closing price recorded in peer market summaries, and the company finished the first quarter with about $1.8 billion of liquidity. The stock had also gained 9.2% over the prior 30 days before the latest drop. That kind of balance-sheet runway matters in eVTOL because certification, manufacturing setup, and pre-launch losses all take longer than management teams initially hope. Investors can reasonably argue that Archer has enough capital to stay in the race through more delays.
Still, cash is not the same thing as technical proof. The most important Archer-specific issue in today’s materials is the missing publicly disclosed piloted transition flight for Midnight. The Yahoo Finance article and the Simply Wall St framing cited in the draft both treat that milestone as a meaningful test of whether Archer’s launch schedule deserves confidence. Archer continues to guide to initial U.S. operations in 2026, but a timeline like that should be judged against visible evidence, not just management ambition. My view is that when a company is promoting a near-dated launch window, absence of a public proof point becomes more important, not less.
The financial profile sharpens that concern. StocksToTrade reported only about $1.6 million of first-quarter revenue against a $217.7 million net loss, while the daily notes also flagged cash burn and Form 144-related selling pressure as part of the June 5 weakness. MarketBeat separately noted that Alta Fundamental Advisers sold 170,500 shares, a reduction of roughly 12.7% in that position. None of those figures imply Archer is in immediate financial trouble; in fact, the opposite is true. They do imply that the valuation conversation should center on execution credibility rather than survival. I am skeptical of any thesis that treats liquidity as a substitute for milestone delivery.
The relative comparison with Joby matters here too. Joby is dealing with supply pressure, but investors at least have more visible discussion around demonstrations and the consequences of financing choices. Archer’s problem is subtler. The stock can look optically cheap versus a $10.61 target, yet still deserve a discount if the most visible flight-test milestone has not been publicly demonstrated. The way I see it, that is why the market may be underpricing schedule risk even after a sharp one-day drop. A company can have plenty of cash and still disappoint if program proof lags public expectations.
My directional lean is cautious to skeptical on the current comfort level embedded in Archer’s story. I am not arguing that Archer lacks the resources to keep moving. I am arguing that investors should demand more hard evidence before rewarding 2026 launch narratives with a higher multiple. The core support for that stance comes from Yahoo Finance, StocksToTrade, and MarketBeat. Until the public flight-test record catches up, cash alone should not close Archer’s valuation gap.
Has EHang’s bottleneck shifted from certification to real-world route approvals and city rollout?
Yes, and that shift is probably the most important analytical change in the EHang story right now. UBS cut EHang from Buy to Neutral and slashed its target price from $21.00 to $11.10, a 47.1% reduction. The same report lowered the 2025 revenue outlook by about 18%, cut 2026 through 2028 shipment and revenue forecasts by 50% to 70%, and pushed breakeven out to 2029 or 2030. Those are not minor valuation tweaks. They amount to a reset in how quickly the market should expect certification success to translate into commercial scale.
What stands out is that the downgrade was not framed around a failure to obtain core aircraft approvals. The source set says EHang’s EH216-S already secured the production and airworthiness certifications that once carried the bull case. UBS instead focused on slower commercialization and the company’s dependence on government approvals for operations in Hefei and Guangzhou. That distinction matters a lot. It means the market is no longer asking, “Can EHang get certified?” It is asking, “How fast can certification turn into repeatable, revenue-generating service in actual cities?” My read is that this is a tougher question because it depends on local operating permissions, route activation, and municipal rollout rather than a single technical milestone.
The market data reinforces that reset. EHang closed at $7.90, down 14.46%, on 3,143,312 shares, while peer names were also weak. At the same time, the macro backdrop was not doing long-duration growth names any favors. The daily file recorded the U.S. 10-year Treasury yield at about 4.522% and the effective federal funds rate around 3.62%. I think that macro context matters because higher discount rates make investors much less patient with commercialization delays. When the market is already demanding faster proof of monetization, a slower city-by-city ramp becomes more damaging to valuation.
This is why certification alone no longer looks like the right investment lens for EH. Certification gave EHang a first-mover narrative. It did not guarantee a fast operating ramp or a near-term path to breakeven. If analysts are willing to cut multi-year shipment and revenue assumptions by half or more, then the market is telling investors to move downstream in their analysis. The way I see it, the next rerating variable is whether Hefei and Guangzhou approvals translate into visible routes, repeat flights, and enough throughput to validate the model. Without that, certification remains a strategic asset but not a valuation shield.
My directional lean is cautious, with upside dependent on commercial proof rather than new technical paperwork. Investors should now analyze EHang as an operations-ramp story, not just a certification story. That conclusion is supported by GuruFocus, the market summary links embedded in the daily report, and the same macro squeeze that is weighing on the broader eVTOL group. If city approvals start turning into real route openings, sentiment can recover. If not, the bottleneck has clearly moved.
What to Watch Tomorrow
First, watch whether Joby’s trading volume eases meaningfully, because that would be the first sign that the post-financing supply shock is starting to clear.
Second, watch for any Archer disclosure tied to piloted transition testing, because even one concrete public milestone would matter more than another generic liquidity reassurance.
Third, watch for EHang updates connected to Hefei or Guangzhou operating permissions, because commercialization speed is now the clearest trigger for the next valuation move.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/06/05/evtol-daily-insight-2026-06-05/